POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19

Detalles Bibliográficos
Autores principales: MBENGUE, M., bigirimana, B., dial, M.C., abdou, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854902/
http://dx.doi.org/10.1016/j.ekir.2022.01.897
_version_ 1784653535141429248
author MBENGUE, M.
bigirimana, B.
dial, M.C.
abdou, N.
author_facet MBENGUE, M.
bigirimana, B.
dial, M.C.
abdou, N.
author_sort MBENGUE, M.
collection PubMed
description
format Online
Article
Text
id pubmed-8854902
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88549022022-02-18 POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19 MBENGUE, M. bigirimana, B. dial, M.C. abdou, N. Kidney Int Rep Article Published by Elsevier Inc. 2022-02 2022-02-18 /pmc/articles/PMC8854902/ http://dx.doi.org/10.1016/j.ekir.2022.01.897 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
MBENGUE, M.
bigirimana, B.
dial, M.C.
abdou, N.
POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title_full POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title_fullStr POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title_full_unstemmed POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title_short POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
title_sort pos-859 recurrence or reactivation of sars-cov-2 infection after immunosuppressive therapy in anca-associated vasculitis with covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854902/
http://dx.doi.org/10.1016/j.ekir.2022.01.897
work_keys_str_mv AT mbenguem pos859recurrenceorreactivationofsarscov2infectionafterimmunosuppressivetherapyinancaassociatedvasculitiswithcovid19
AT bigirimanab pos859recurrenceorreactivationofsarscov2infectionafterimmunosuppressivetherapyinancaassociatedvasculitiswithcovid19
AT dialmc pos859recurrenceorreactivationofsarscov2infectionafterimmunosuppressivetherapyinancaassociatedvasculitiswithcovid19
AT abdoun pos859recurrenceorreactivationofsarscov2infectionafterimmunosuppressivetherapyinancaassociatedvasculitiswithcovid19

Ejemplares similares